期刊文献+

纤维蛋白原与淋巴细胞比值在评估老年食管鳞癌放疗预后中的价值 被引量:3

The value of fibrinogen to lymphocyte ratio in evaluating the prognosis of elderly patients with esophageal squamous cell carcinoma
下载PDF
导出
摘要 目的探讨纤维蛋白原与淋巴细胞比值(FLR)所建立的新型预测模型在评价老年食鳞癌病人放疗近期疗效和预后的价值。方法收集2014年1月至2018年1月徐州医科大学附属医院放射治疗科接受放射治疗并符合入组条件的老年食管癌127例资料。根据受试者ROC曲线求得纤维蛋白原与淋巴细胞比值对的最佳截断值,并以此计算FLR水平与食管鳞癌临床病理特征和预后的关系。结果受试者工作特征曲线(ROC)显示,放疗前FLR的最佳截断值为2.05。根据2.05将127例病人分为低FLR(n=56例)和高FLR(n=71例)。不同FLR水平病人累积生存率经log-rank检验结果显示,FLR高水平病人共56例,生存时间为(23.87±4.05)月,FLR低水平组共71例,生存时间为(55.21±3.99)月,FLR高水平者明显低于FLR低水平者,差异有统计学意义(P<0.05)。低FLR组放疗有效率为91.0%,高FLR组有效率为71.8%,差异有统计学意义(P<0.05)。单因素分析显示,FLR、N分期、T分期、TNM分期是影响老年食管鳞癌病人总生存(Overall survival,OS)的因素,多因素分析显示,FLR、N分期是影响老年食管鳞癌病人OS的因素。结论高水平的FLR提示老年食管鳞癌病人放疗近期疗效、预后均较差。 Objective To explore the value of a new prediction model based on the ratio of fibrinogen to lymphocyte(FLR)in evaluating the short-term efficacy and prognosis of radiotherapy in elderly patients with esophagal squamous cell carcinoma.Methods From January 2014 to January 2018,127 elderly patients with esophageal cancer who received radiotherapy in the Radiotherapy Department of Affiliated Hospital of Xuzhou Medical University were collected.According to the operating characteristic curve(ROC)of the subjucts,the best cutoff value of the fibrinogen to lymphocyte ratio was obtained,and the relationship between FLR level and clinicopathological characteristics and prognosis of ESCC was calculated.Results ROC showed that the best cutoff value of FLR before radiotherapy was 2.05.According to 2.05,127 patients were divided into low FLR(n=56)and high FLR(n=71).The cumulative survival rate of patients with different FLR levels by log-rank test showed that 56 patients with high FLR had a survival time of(23.87±4.05)months,and 71 patients with low FLR had a survival time of(55.21±3.99)months.The survival time in patients with high FLR level was significantly lower than that of the low FLR level,and the difference was statistically significant(P<0.05),and the effective rate in the high FLR group was 71.8%.The difference was statistically significant(P<0.05).Single factor analysis showed that FLR,N stage,T stage and TNM stage were the factors influencing the overall survival(OS)of elderly patients with esophageal squamous cell carcinoma.Multi-factor analysis showed that FLR and N stage were the factors influencing OS in elderly patients with esophageal squamous cell carcinoma.Conclusion High level of FLR is indicative of poor short-term efficacy and prognosis of radiotherapy in the elderly patients with esophageal squamous cell carcinoma.
作者 姚若愚 展浩 鲍强 张旭光 YAO Ruoyu;ZHAN Hao;BAO Qiang;ZHANG Xuguang(Graduate School of Xuzhou Medical University,Xuzhou,Jiangsu 221004,China;Xuzhou Tumor Hospital,Xuzhou,Jiangsu 221000,China)
出处 《安徽医药》 CAS 2021年第10期1972-1976,共5页 Anhui Medical and Pharmaceutical Journal
基金 江苏省自然科学基金项目(BK20151156)。
关键词 食管肿瘤 纤维蛋白原 淋巴细胞计数 纤维蛋白原与淋巴细胞比值 预后 老年人 Esophageal neoplasms Fibrinogen Lymphocyte count Fibrinogen to lymphocyte ratio Prognosis Aged
  • 相关文献

参考文献5

二级参考文献23

共引文献544

同被引文献13

  • 1刘荫华,姚宏伟,周斌,辛灵.美国肿瘤联合会结直肠癌分期系统(第8版)更新解读[J].中国实用外科杂志,2017,37(1):6-9. 被引量:90
  • 2徐金良,杜丹丹,翟志敏,郭进京.卵巢良恶性肿瘤患者血液NLR,LMR,RDW,PLR四项参数的变化及其临床意义[J].现代检验医学杂志,2018,33(2):16-18. 被引量:18
  • 3殷凯,瞿建国,陈吉祥,赵小辉,党胜春.胃癌神经侵犯的相关临床病理因素:单中心509例分析[J].中国普通外科杂志,2018,27(4):396-400. 被引量:7
  • 4李然天,孙紫千,王红兵.纤维蛋白原与前白蛋白比值对中晚期非小细胞肺癌预后作用的研究[J].临床肿瘤学杂志,2019,24(3):237-241. 被引量:17
  • 5葛国朝,张正君,李光耀.外周血中性粒细胞和淋巴细胞比值、营养指数及体质量指数与胃癌预后关系[J].安徽医药,2019,23(5):876-880. 被引量:13
  • 6李卿英.膀胱尿路上皮细胞癌患者外周血NLR,PLR,MLR和RDW水平表达及在临床分期评估中的价值[J].现代检验医学杂志,2020,35(4):89-93. 被引量:6
  • 7金萍,王亚萍,孙兵,龚芳,卢志贤.血浆D-二聚体、纤维蛋白原含量、AT-Ⅲ活性的测定在恶性肿瘤诊断中的临床价值[J].临床与病理杂志,2020,40(10):2534-2537. 被引量:8
  • 8刘书豪,侯新月,张宪祥,刘广伟,信芳杰,王继刚,张佃良,王东升,卢云.进展期胃癌神经侵犯列线图预测模型的构建与验证[J].中华胃肠外科杂志,2020,23(11):1059-1066. 被引量:12
  • 9H.Agakishiev,M.M.Aggarwal,Z.Ahammed,A.V.Alakhverdyants,I.Alekseev,J.Alford,B.D.Anderson,C.D.Anson,D.Arkhipkin,G.S.Averichev,J.Balewski,D.R.Beavis,N.K.Behera,R.Bellwied,M.J.Betancourt,R.R.Betts,A.Bhasin,A.K.Bhat,H.Bichsel,J.Bieleik,J.Bielcikova,B.Biritz,L.C.Bland,W.Borowski,J.Bouchet,E.Braidot,A.V.Brandin,A.Bridgeman,S.G.Brovko,E.Bruna,S.Bueltmann,I.Bunzarov,T.P.Burton,X.Z.Cai,H.Caines,M.Calderon de la Barca Sanchez,D.Cebra,R.Cendejas,M.C.Cervantes,Z.Chajecki,P.Chaloupka,S.Chattopadhyay,H.F.Chen,J.H.Chen,J.Y.Chen,L.Chen,J.Cheng,M.Cherney,A.Chikanian,K.E.Choi,W.Christie,P.Chung,M.J.M.Codrington,R.Corliss,J.G.Cramer,H.J.Crawford,S.Dash,A.Davila Leyva,L.C.De Silvat,R.R.Debbe,T.G.Dedovich,A.A.Derevschikov,R.Derradi de Souza,L.Didenko,P.Djawotho,S.M.Dogra,X.Dong,J.L.Drachenberg,J.E.Draper,J.C.Dunlop,L.G Efimov,M.Elnim,J.Engelage,G Eppley,M.Estienne,L.Eun,O.Evdokimov,R.Fatemi,J.Fedorisin,A.Feng,R.G.Fersch,P.Filip,E.Finch,V.Fine,Y.Fisyak,C.A.Gagliardi,D.R.Gangadharan,A.Geromitsos,F.Geurts,P.Ghosh,Y.N.Gorbunov,A.Gordon,O.Grebenyuk,D.Grosnick,S.M.Guertin,A.Gupta,W.Guryn,B.Haag,O.Hajkova,A.Hamed,L-X.Han,J.W.Harris,J.P.Hays-Wehle,M.Heinz,S.Heppelmann,A.Hirsch,E.Hjort,G.W.Hoffmann,D.J.Hofiman,B.Huang,H.Z.Huang,T.J.Humanic,L.Huo,G.Igo,P.Jacobs,W.W.Jacobs,C.Jena,F.Jin,J.Joseph,E.G.Judd,S.Kabana,K.Kang,J.Kapitan,K.Kauder,H.Ke,D.Keane,A.Kechechyan,D.Kettler,D.P.Kikola,J.Kiryluk,A.Kisiel,V.Kizka,A.G.Knospe,D.D.Koetke,T.Kollegger,J.Konzer,I.Koralt,L.Koroleva,W.Korsch,L.Kotchenda,V.Kouchpil,P.Kravtsov,K.Krueger,M.Krus,L.Kumar,P.Kurnadi,M.A.C.Lamont,J.M.Landgraf,S.LaPointe,J.Lauret,A.Lebedev,R.Lednicky,J.H.Lee,W.Leight,M.J.LeVine,C.Lil,L.Li,N.Li,W.Li,X.Li,X.Li,Y.Li,Z.M.Li,M.A.Lisa,F.Liu,H.Liu,J.Liu,T.Ljubicic,W.J.Llope,R.S.Longacre,W.A.Love,Y.Lu,E.V.Lukashov,X.Luo,G.L.Ma,Y.G.Mai,D.P.Mahapatra,R.Majka,O.I.Mall,L.K.Mangotra,R.Manweiler,S.Margetis,C.Markert,H.Masui,H.S.Matis,Yu.A.Matulenko,D.MeDonald,T.S.McShane,A.Meschanin,R.Milner,N.G.Minaev,S.Mioduszewski,A.Mischke,M.K.Mitrovski,B.Mohanty,M.M.Mondal,B.Morozov,D.A.Morozov,M.G.Munhoz,M.Naglis,B.K.Nandi,T.K.Nayak,P.K.Netrakanti,L.V.Nogach,S.B.Nurushev,G.Odyniec,A.Ogawa,Oh,Ohlson,V.Okorokov,E.W.Oldag,D.Olsont,M.Pachr,B.S.Page,S.K.Pal,Y.Pandit,Y.Panebratsev,T.Pawlak,H.Pei,T.Peitzmann,C.Perkins,W.Peryt,S.C.Phatak,P.Pile,M.Planinic,M.A.Ploskon,J.Pluta,D.Plyku,N.Poljak,A.M.Poskanzer,B.V.K.S.Potukuchi,C.B.Powell,D.Prindle,N.K.Pruthi,A.M.Poskanzer,B.V.K.S.Potukuchi,B.Powell,D.Prindle,N.K.Pruthi,P.R.Pujahar,J.Putschke,H.Qiu,R.Raniwala,S.Raniwala,R.L.Ray,R.Redwine,R.Reed,H.G.Riter,J.B.Roberts,O.V.Rogachevskiy,J.L.Romero,A.Rose,L.Ruan,J.Rusnak,N.R.Sahoo,S.Sakai,I.Sakrejda,T.Sakuma,S.Salur,J.Sandweiss,E.Sangaline,A.Sarkar,J.Schambach,R.P.Scharenberg,A.M.Schmah,N.Schmitz,T.R.Schuster,J.Seele,J.Seger,I.Selyuzhenkov,P.Seyboth,E.Shahaliev,M.Shao,M.Sharma,S.S.Shi,Q.Y.Shou,E.P.Sichtermann,F.Simon,R.N.Singaraju,M.J.Skoby,N.Smirnov,H.M.Spinka,B.Srivastava,T.D.S.Stanislaus,D.Staszak,S.G.Steadman,J.R.Stevens,R.Stock,M.Strikhanov,B.Stringfellow,A.A.P.Suaide,M.C.Suarez,N.L.Subba,M.Sumbera,X.M.Sun,Y.Sun,Z.Sun,B.Surrow,D.N.Svirida,T.J.M.Symons,A.Szanto de Toledo,J.Takahashi,A.H.Tang,Z.Tang,L.H.Tarini,T.Tarnowsky,D.Thein,J.H.Thomas,J.Tian,A.R.Timmins,D.Tlusty,M.Tokarev,V.N.Tram,S.Trentalange,R.E.Tribble,Tribedy,O.D.Tsai,T.Ullrich,D.G.Underwood,G.Van Buren,G.van Nieuwenhuizen,J.A.Vanfossen,R.Varma,G.M.S.Vasconcelos,A.N.Vasiliev,F.Videbaek,Y.P.Viyogi,S.Vokal,M.Wadat,M.Walker,F.Wang,G.Wang,H.Wang,J.S.Wang,Q.Wang,X.L.Wang,Y.Wang,G.Webb,J.C.Webb,G.D.Westfall,C.Whitten,H.Wieman,S.W.Wissink,R.Witt,W.Witzke,Y.F.Wu,Xiao,W.Xie,H.Xu,N.Xu,Q.H.Xu,W.Xu,Y.Xu,Z.Xu,L.Xue,Y.Yang,P.Yepes,K.Yip,I-K.Yoo,M.Zawisza,H.Zbroszczyk,W.Zhan,J.B.Zhang,S.Zhang,W.M.Zhang,X.P.Zhang,Y.Zhang,Z.P.Zhang,J.Zhao,C.Zhong,W.Zhou,X.Zhu,Y.H.Zhu,R.Zoulkarneev,Y.Zoulkarneeva.Measurements of dihadron correlations relative to the event plane in Au+Au collisions at√^(S)NN=200 GeV[J].Chinese Physics C,2021,45(4):198-241. 被引量:351
  • 10刘宗超,李哲轩,张阳,周彤,张婧莹,游伟程,潘凯枫,李文庆.2020全球癌症统计报告解读[J].肿瘤综合治疗电子杂志,2021,7(2):1-13. 被引量:1166

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部